Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2017, including consolidated revenues of $2.27 billion, compared to revenues of $2.48 billion in the second quarter of 2016. Quarterly net income was $20.1 million, or $0.33 per share, compared to $27.7 million, or $0.45 per share, for the second quarter last year. Adjusted net income (non-GAAP) was $25.8 million, or $0.43 per share, compared to $0.55 per share in last year’s second quarter.
With the closing of the Byram Healthcare acquisition, Owens & Minor has adopted a revised non-GAAP presentation that excludes amortization of acquisition-related intangible assets in addition to items currently excluded. A reconciliation of reported results to adjusted (non-GAAP) measures is included below. Similar to the first quarter of 2017, the quarterly decrease in revenues and earnings resulted primarily from the previously discussed transition of a significant customer in 2016, as well as increased production costs in our Proprietary Products segment and ongoing margin pressure in our Domestic distribution business. Offsetting these factors were benefits from cost control and productivity initiatives, as well as a one-time benefit from the release of an income tax valuation allowance in Europe, resulting from improved operating performance.
Consolidated operating earnings for the second quarter of 2017 were $32.8 million, compared to $52.1 million in last year’s second quarter. Adjusted consolidated operating earnings (non-GAAP) for the second quarter were $41.4 million, compared to $61.3 million for the same period last year.
“We are pleased to have successfully closed the acquisition of Byram Healthcare, and we welcome these new teammates into our organization. Acquiring Byram Healthcare represents an important step toward accelerating our strategy to expand our services along the continuum of care,” said P. Cody Phipps, chairman, president & chief executive officer of Owens & Minor. “As we have previously said, the first half of 2017 was challenging, but we remain committed to improving our performance, as we continue to execute our strategy.”
Year-to-Date 2017 Results
For the first six months of 2017, consolidated revenues were $4.59 billion, compared to revenues of $4.94 billion in the first six months of 2016. Net income for the first half of the year was $38.9 million, or $0.64 per share, compared to $0.83 per share for the same period last year. Adjusted net income (non-GAAP) was $52.3 million, or $0.86 per share, compared to $1.08 per share in the first six months of last year.
Consolidated operating earnings for the first half of 2017 were $68.4 million, compared to $97.0 million in the same period last year. Adjusted consolidated operating earnings (non-GAAP) for the first six months of 2017 were $89.1 million, compared to $119 million for the same period last year.
Acquisition of Byram Healthcare
Owens & Minor also announced that it has closed the previously announced acquisition of Byram Healthcare for $380 million. Byram Healthcare, a leading national distributor of direct-to-patient medical supplies, will accelerate Owens & Minor’s strategic plan to expand its services along the continuum of care. As part of the transaction, Owens & Minor executed a refinancing of its bank credit facility and expanded it to $600 million and executed a term loan of $250 million, both of which are due in 2022. Owens & Minor expects the transaction to be modestly accretive to earnings in 2017, and anticipates further accretion to earnings in 2018.
Segment Results
Segment financial results for the quarter are shown in the financial tables included with this release. Segment results include:
- Domestic Segment quarterly revenues were $2.13 billion, compared to $2.35 billion a year ago; operating earnings were $29.5 million, compared to $43.5 million for the same period last year.
- International Segment quarterly revenues were $95.9 million, compared to $88.6 million last year; operating earnings were $0.8 million, compared to $0.9 million in last year’s second quarter.
- Proprietary Products Segment quarterly revenues were $131 million, compared to $135 million in the prior year quarter; operating earnings were $8.8 million versus $14.3 million last year.
Revised Financial Guidance and Outlook
As a result of the closing of the Byram Healthcare transaction and the adoption of a revised non-GAAP presentation, Owens & Minor is revising its guidance on an adjusted basis (non-GAAP) for 2017 and 2018. The revised outlook for non-GAAP diluted earnings per share in 2017 is $1.90 to $2.00. For 2018, the company is updating guidance to $2.25 to $2.35 per share on an adjusted basis (non-GAAP). The company believes that its strategic plan and the acquisition of Byram Healthcare will enable Owens & Minor to achieve its stated goal of high single-digit growth rates in subsequent years.
Although the company does provide guidance for adjusted earnings per share (which is a non-GAAP financial measure), it is not able to forecast the most directly comparable measure calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for the company to forecast. Such elements include, but are not limited to restructuring and acquisition charges. As a result, no GAAP guidance is provided. The outlook is based on certain assumptions that are subject to the risk factors discussed in the company’s filings with the Securities & Exchange Commission.
Investors Conference Call & Supplemental Material
Conference Call: Owens & Minor will conduct a conference call for investors on Wednesday, August 2, 2017, at 8:00 a.m. EDT. The access code for the conference call, international dial-in and replay is #57721689. Participants may access the call at 866-393-1604. The international dial-in number is 224-357-2191. Replay: A replay of the call will be available for one week by dialing 855-859-2056. Webcast: A listen-only webcast of the call, along with supplemental information, will be available on www.owens-minor.com under “Investor Relations.”
Safe Harbor Statement
This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the Securities and Exchange Commission's Fair Disclosure Regulation. This release contains certain ''forward-looking'' statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including financial guidance for 2017 and 2018 and growth rates in subsequent years. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Investors should refer to our annual report on Form 10-K for the year ended December 31, 2016, filed with the Securities and Exchange Commission ("SEC") and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause our actual results to differ materially from our current estimates. These filings are available at www.owens-minor.com. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. We specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
Owens & Minor uses its Web site, www.owens-minor.com, as a channel of distribution for material company information, including news releases, investor presentations and financial information. This information is routinely posted and accessible under the Investor Relations section.
Included with the press release financial tables are reconciliations of the differences between the non-GAAP financial measures presented in this news release and their most directly comparable GAAP financial measures.
About Owens & Minor, Inc.
Owens & Minor, Inc. (NYSE: OMI) is a global healthcare services company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor’s customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, and the federal government. A FORTUNE 500 company, Owens & Minor is headquartered in Richmond, Virginia, and has annualized revenues exceeding $9 billion. For more information about Owens & Minor, visit owens-minor.com, follow @Owens_Minor on Twitter, and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.
Owens & Minor, Inc. Consolidated Statements of Income (unaudited) (dollars in thousands, except per share data) | ||||||||||
| Three Months Ended June 30, | ||||||||||
| 2017 | 2016 | |||||||||
| Net revenue | $ | 2,265,907 | $ | 2,483,676 | ||||||
| Cost of goods sold | 1,992,374 | 2,184,256 | ||||||||
| Gross margin | 273,533 | 299,420 | ||||||||
| Distribution, selling and administrative expenses | 236,615 | 242,914 | ||||||||
| Acquisition-related and exit and realignment charges | 2,893 | 6,752 | ||||||||
| Other operating (income) expense, net | 1,188 | (2,300 | ) | |||||||
| Operating earnings | 32,837 | 52,054 | ||||||||
| Interest expense, net | 6,736 | 6,765 | ||||||||
| Income before income taxes | 26,101 | 45,289 | ||||||||
| Income tax provision | 5,960 | 17,573 | ||||||||
| Net income | $ | 20,141 | $ | 27,716 | ||||||
| Net income per common share: | ||||||||||
| Basic | $ | 0.33 | $ | 0.45 | ||||||
| Diluted | $ | 0.33 | $ | 0.45 | ||||||
| Six Months Ended June 30, | ||||||||||
| 2017 | 2016 | |||||||||
| Net revenue | $ | 4,594,480 | $ | 4,939,469 | ||||||
| Cost of goods sold | 4,039,768 | 4,343,413 | ||||||||
| Gross margin | 554,712 | 596,056 | ||||||||
| Distribution, selling and administrative expenses | 474,308 | 485,639 | ||||||||
| Acquisition-related and exit and realignment charges | 11,835 | 17,235 | ||||||||
| Other operating (income) expense, net | 216 | (3,842 | ) | |||||||
| Operating earnings | 68,353 | 97,024 | ||||||||
| Interest expense, net | 13,480 | 13,554 | ||||||||
| Income before income taxes | 54,873 | 83,470 | ||||||||
| Income tax provision | 15,947 | 31,619 | ||||||||
| Net income | $ | 38,926 | $ | 51,851 | ||||||
| Net income per common share: | ||||||||||
| Basic | $ | 0.64 | $ | 0.83 | ||||||
| Diluted | $ | 0.64 | $ | 0.83 | ||||||
Owens & Minor, Inc. Condensed Consolidated Balance Sheets (unaudited) (dollars in thousands) | |||||||||||
| June 30, 2017 | December 31, 2016 | ||||||||||
| Assets | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ | 57,066 | $ | 185,488 | |||||||
| Accounts receivable, net | 655,259 | 606,084 | |||||||||
| Merchandise inventories | 1,004,076 | 916,311 | |||||||||
| Other current assets | 306,452 | 254,156 | |||||||||
| Total current assets | 2,022,853 | 1,962,039 | |||||||||
| Property and equipment, net | 198,442 | 191,718 | |||||||||
| Goodwill, net | 423,107 | 414,936 | |||||||||
| Intangible assets, net | 80,051 | 82,511 | |||||||||
| Other assets, net | 70,684 | 66,548 | |||||||||
| Total assets | $ | 2,795,137 | $ | 2,717,752 | |||||||
| Liabilities and equity | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable | $ | 798,454 | $ | 750,750 | |||||||
| Accrued payroll and related liabilities | 23,819 | 45,051 | |||||||||
| Other current liabilities | 241,091 | 238,837 | |||||||||
| Total current liabilities | 1,063,364 | 1,034,638 | |||||||||
| Long-term debt, excluding current portion | 579,117 | 564,583 | |||||||||
| Deferred income taxes | 89,812 | 90,383 | |||||||||
| Other liabilities | 69,273 | 68,110 | |||||||||
| Total liabilities | 1,801,566 | 1,757,714 | |||||||||
| Total equity | 993,571 | 960,038 | |||||||||
| Total liabilities and equity | $ | 2,795,137 | $ | 2,717,752 | |||||||
Owens & Minor, Inc. Consolidated Statements of Cash Flows (unaudited) (dollars in thousands) | |||||||||||||
| Six Months Ended June 30, | |||||||||||||
| 2017 | 2016 | ||||||||||||
| Operating activities: | |||||||||||||
| Net income | $ | 38,926 | $ | 51,851 | |||||||||
| Adjustments to reconcile net income to cash (used for) provided by operating activities: | |||||||||||||
| Depreciation and amortization | 25,206 | 28,343 | |||||||||||
| Share-based compensation expense | 5,619 | 5,969 | |||||||||||
| Provision for losses on accounts receivable | (368 | ) | (27 | ) | |||||||||
Deferred income tax (benefit) expense | (5,385 | ) | (2,071 | ) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||||
| Accounts receivable | (41,863 | ) | (29,736 | ) | |||||||||
| Merchandise inventories | (86,234 | ) | (17,947 | ) | |||||||||
| Accounts payable | 42,235 | 62,710 | |||||||||||
| Net change in other assets and liabilities | (66,003 | ) | (56,599 | ) | |||||||||
| Other, net | 5,371 | 743 | |||||||||||
| Cash (used for) provided by operating activities | (82,496 | ) | 43,236 | ||||||||||
| Investing activities: | |||||||||||||
| Additions to property and equipment | (16,433 | ) | (8,857 | ) | |||||||||
| Additions to computer software and intangible assets | (7,860 | ) | (4,602 | ) | |||||||||
| Proceeds from sale of property and equipment | 573 | 4,565 | |||||||||||
| Cash used for investing activities | (23,720 | ) | (8,894 | ) | |||||||||
| Financing activities: | |||||||||||||
| Proceeds from revolving credit facility | 15,400 | — | |||||||||||
| Cash dividends paid | (31,476 | ) | (32,003 | ) | |||||||||
| Repurchases of common stock | (4,998 | ) | (20,849 | ) | |||||||||
| Other, net | (5,658 | ) | (5,968 | ) | |||||||||
| Cash used for financing activities | (26,732 | ) | (58,820 | ) | |||||||||
| Effect of exchange rate changes on cash and cash equivalents | 4,526 | 2,409 | |||||||||||
| Net decrease in cash and cash equivalents | (128,422 | ) | (22,069 | ) | |||||||||
| Cash and cash equivalents at beginning of period | 185,488 | 161,020 | |||||||||||
| Cash and cash equivalents at end of period | $ | 57,066 | $ | 138,951 | |||||||||
Owens & Minor, Inc. Financial Statistics and GAAP/Non-GAAP Reconciliations (unaudited) | ||||||||||||||||||||||||||||
| (dollars in thousands, except per share data) | Quarter Ended | |||||||||||||||||||||||||||
| 6/30/2017 | 3/31/2017 | 12/31/2016 | 9/30/2016 | 6/30/2016 | ||||||||||||||||||||||||
| Consolidated operating results: | ||||||||||||||||||||||||||||
| Net revenue | $ | 2,265,907 | $ | 2,328,573 | $ | 2,368,361 | $ | 2,415,601 | $ | 2,483,676 | ||||||||||||||||||
| Gross margin | $ | 273,533 | $ | 281,180 | $ | 294,980 | $ | 296,275 | $ | 299,420 | ||||||||||||||||||
| Gross margin as a percent of revenue | 12.07 | % | 12.08 | % | 12.46 | % | 12.27 | % | 12.06 | % | ||||||||||||||||||
| Distribution, selling & administrative expenses | $ | 236,615 | $ | 237,693 | $ | 243,480 | $ | 241,305 | $ | 242,914 | ||||||||||||||||||
| Distribution, selling & administrative expenses as a percent of revenue | 10.44 | % | 10.21 | % | 10.28 | % | 9.99 | % | 9.78 | % | ||||||||||||||||||
| Operating earnings, as reported (GAAP) | $ | 32,837 | $ | 35,517 | $ | 49,008 | $ | 53,568 | $ | 52,054 | ||||||||||||||||||
| Acquisition-related charges (1) | 692 | 1,347 | 286 | 597 | 730 | |||||||||||||||||||||||
| Exit and realignment charges (2) | 2,201 | 7,595 | 4,415 | 2,142 | 6,022 | |||||||||||||||||||||||
| Acquisition-related intangible amortization (3) | 2,347 | 2,319 | 2,450 | 2,489 | 2,538 | |||||||||||||||||||||||
| Other (4) | 3,311 | 922 | — | — | — | |||||||||||||||||||||||
| Operating earnings, adjusted (Non-GAAP) | $ | 41,388 | $ | 47,700 | $ | 56,159 | $ | 58,796 | $ | 61,344 | ||||||||||||||||||
| Operating earnings as a percent of revenue (GAAP) | 1.45 | % | 1.53 | % | 2.07 | % | 2.22 | % | 2.10 | % | ||||||||||||||||||
| Operating earnings as a percent of revenue, adjusted (Non-GAAP) | 1.83 | % | 2.05 | % | 2.37 | % | 2.43 | % | 2.47 | % | ||||||||||||||||||
| . | ||||||||||||||||||||||||||||
| Net income, as reported (GAAP) | $ | 20,141 | $ | 18,785 | $ | 27,105 | $ | 29,831 | $ | 27,716 | ||||||||||||||||||
| Acquisition-related charges(1) | 692 | 1,347 | 286 | 597 | 730 | |||||||||||||||||||||||
| Income tax expense (benefit) (5) | (228 | ) | (450 | ) | 67 | (221 | ) | (164 | ) | |||||||||||||||||||
| Exit and realignment charges (2) | 2,201 | 7,595 | 4,415 | 2,142 | 6,022 | |||||||||||||||||||||||
| Income tax expense (benefit) (5) | (780 | ) | (3,055 | ) | (289 | ) | (794 | ) | (2,081 | ) | ||||||||||||||||||
| Acquisition-related intangible amortization (3) | 2,347 | 2,319 | 2,450 | 2,489 | 2,538 | |||||||||||||||||||||||
| Income tax expense (benefit) (5) | (696 | ) | (696 | ) | (633 | ) | (645 | ) | (658 | ) | ||||||||||||||||||
| Other (4) | 3,311 | 922 | — | — | — | |||||||||||||||||||||||
| Income tax expense (benefit) (5) | (1,139 | ) | (354 | ) | — | — | — | |||||||||||||||||||||
| Net income, adjusted (Non-GAAP) | $ | 25,849 | $ | 26,413 | $ | 33,401 | $ | 33,399 | $ | 34,103 | ||||||||||||||||||
| Net income per share, as reported (GAAP) | $ | 0.33 | $ | 0.31 | $ | 0.45 | $ | 0.48 | $ | 0.45 | ||||||||||||||||||
| Acquisition-related charges, after-tax (1) | 0.01 | 0.01 | — | 0.01 | 0.01 | |||||||||||||||||||||||
| Exit and realignment charges, after-tax (2) | 0.02 | 0.08 | 0.07 | 0.02 | 0.06 | |||||||||||||||||||||||
| Acquisition-related intangible amortization, after-tax (3) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |||||||||||||||||||||||
| Other, after-tax (4) | 0.04 | 0.01 | — | — | — | |||||||||||||||||||||||
| Net income per share, adjusted (Non-GAAP) | $ | 0.43 | $ | 0.44 | $ | 0.55 | $ | 0.54 | $ | 0.55 | ||||||||||||||||||
| Financing: | ||||||||||||||||||||||||||||
| Cash and cash equivalents | $ | 57,066 | $ | 127,167 | $ | 185,488 | $ | 213,096 | $ | 138,951 | ||||||||||||||||||
| Total interest-bearing debt | $ | 583,201 | $ | 568,565 | $ | 569,387 | $ | 570,263 | $ | 571,143 | ||||||||||||||||||
| Stock information: | ||||||||||||||||||||||||||||
| Cash dividends per common share | $ | 0.2575 | $ | 0.2575 | $ | 0.255 | $ | 0.255 | $ | 0.255 | ||||||||||||||||||
| Stock price at quarter-end | $ | 32.19 | $ | 34.60 | $ | 35.29 | $ | 34.73 | $ | 37.38 | ||||||||||||||||||
Owens & Minor, Inc. |
Financial Statistics and GAAP/Non-GAAP Reconciliations (unaudited) |
The following items in the current quarter have been excluded in our non-GAAP financial measures:
(1) Acquisition-related charges in the first and second quarters of 2017 were primarily transaction and transition costs associated with the acquisition of Byram Healthcare. The prior year amounts related primarily to costs incurred to settle certain obligations and address other on-going matters associated with the acquisitions of ArcRoyal and Medical Action.
(2) Exit and realignment charges in 2017 were associated with the write-down of information system assets which are no longer used and severance charges from reduction in force and other employee costs associated with the establishment of our new client engagement center. Expenses associated with the establishment of the client engagement center will continue to be recorded throughout 2017. Charges in 2016 included severance activities (including our voluntary employee separation program in the first quarter of 2016), and other costs associated with our strategic organizational realignment which include certain professional fees and costs to streamline administrative functions and processes in the United States and Europe.
(3) Acquisition-related intangible amortization includes amortization of certain intangible assets established during purchase accounting for business combinations. These amounts are highly dependent on the size and frequency of acquisitions and are being excluded to allow for a more consistent comparison with forecasted, current and historical results and the results of our peers. We have begun to exclude these charges from our non-GAAP results in the second quarter of 2017 and thus prior year amounts have been recast on the same basis. Full year 2016 intangible amortization was $10.0 million or $0.12 per share.
(4) Software as a Service (SaaS) implementation costs associated with significant global IT platforms in connection with the redesign of our global information system strategy.
(5)These charges have been tax effected in the preceding table by determining the income tax rate depending on the amount of charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes.
Use of Non-GAAP Measures |
| This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.’s (the “Company”) core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate the Company’s performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation. |
| Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on its financial and operating results and in comparing the Company’s performance to that of its competitors. However, the non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. |
| The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated. |
Owens & Minor, Inc. Summary Segment Information (unaudited) (dollars in thousands) | ||||||||||||||||||
| Three Months Ended June 30, | ||||||||||||||||||
| 2017 | 2016 | |||||||||||||||||
| % of | % of | |||||||||||||||||
| consolidated | consolidated | |||||||||||||||||
| Amount | net revenue | Amount | net revenue | |||||||||||||||
| Net revenue: | ||||||||||||||||||
| Segment net revenue | ||||||||||||||||||
| Domestic | $ | 2,130,468 | 94.02 | % | $ | 2,345,746 | 94.45 | % | ||||||||||
| International | 95,899 | 4.23 | % | 88,559 | 3.57 | % | ||||||||||||
| Proprietary Products | 130,959 | 5.78 | % | 134,964 | 5.43 | % | ||||||||||||
| Total segment net revenue | 2,357,326 | 2,569,269 | ||||||||||||||||
| Inter-segment revenue | ||||||||||||||||||
| Proprietary Products | (91,419 | ) | (4.03 | )% | (85,593 | ) | (3.45 | )% | ||||||||||
| Total inter-segment revenue | (91,419 | ) | (85,593 | ) | ||||||||||||||
| Consolidated net revenue | $ | 2,265,907 | 100.00 | % | $ | 2,483,676 | 100.00 | % | ||||||||||
| % of segment | % of segment | |||||||||||||||||
| Operating earnings (loss): | net revenue | net revenue | ||||||||||||||||
| Domestic | $ | 29,460 | 1.38 | % | $ | 43,451 | 1.85 | % | ||||||||||
| International | 752 | 0.78 | % | 893 | 1.01 | % | ||||||||||||
| Proprietary Products | 8,810 | 6.73 | % | 14,255 | 10.56 | % | ||||||||||||
| Inter-segment eliminations | 19 | 207 | ||||||||||||||||
| Acquisition-related and exit and realignment charges | (2,893 | ) | (6,752 | ) | ||||||||||||||
| Other (1) | (3,311 | ) | — | |||||||||||||||
| Consolidated operating earnings | $ | 32,837 | 1.45 | % | $ | 52,054 | 2.10 | % | ||||||||||
| Depreciation and amortization: | ||||||||||||||||||
| Domestic | $ | 6,769 | $ | 7,497 | ||||||||||||||
| International | 3,964 | 4,416 | ||||||||||||||||
| Proprietary Products | 1,915 | 2,213 | ||||||||||||||||
| Consolidated depreciation and amortization | $ | 12,648 | $ | 14,126 | ||||||||||||||
| Capital expenditures: | ||||||||||||||||||
| Domestic | $ | 4,986 | $ | 2,659 | ||||||||||||||
| International | 3,431 | 2,860 | ||||||||||||||||
| Proprietary Products | 1,105 | 880 | ||||||||||||||||
| Consolidated capital expenditures | $ | 9,522 | $ | 6,399 | ||||||||||||||
Owens & Minor, Inc. Summary Segment Information (unaudited) (dollars in thousands) | ||||||||||||||||||
| Six Months Ended June 30, | ||||||||||||||||||
| 2017 | 2016 | |||||||||||||||||
| % of | % of | |||||||||||||||||
| consolidated | consolidated | |||||||||||||||||
| Amount | net revenue | Amount | net revenue | |||||||||||||||
| Net revenue: | ||||||||||||||||||
| Segment net revenue | ||||||||||||||||||
| Domestic | $ | 4,324,428 | 94.12 | % | $ | 4,667,455 | 94.49 | % | ||||||||||
| International | 190,894 | 4.15 | % | 172,110 | 3.48 | % | ||||||||||||
| Proprietary Products | 268,112 | 5.84 | % | 276,317 | 5.59 | % | ||||||||||||
| Total segment net revenue | 4,783,434 | 5,115,882 | ||||||||||||||||
| Inter-segment revenue | ||||||||||||||||||
| Proprietary Products | (188,954 | ) | (4.11 | )% | (176,413 | ) | (3.57 | )% | ||||||||||
| Total inter-segment revenue | (188,954 | ) | (176,413 | ) | ||||||||||||||
| Consolidated net revenue | $ | 4,594,480 | 100.00 | % | $ | 4,939,469 | 100.00 | % | ||||||||||
| % of segment | % of segment | |||||||||||||||||
| Operating earnings (loss): | net revenue | net revenue | ||||||||||||||||
| Domestic | $ | 66,756 | 1.54 | % | $ | 85,169 | 1.82 | % | ||||||||||
| International | 1,408 | 0.74 | % | 2,021 | 1.17 | % | ||||||||||||
| Proprietary Products | 16,938 | 6.32 | % | 27,526 | 9.96 | % | ||||||||||||
| Inter-segment eliminations | (681 | ) | (457 | ) | ||||||||||||||
| Acquisition-related and exit and realignment charges | (11,835 | ) | (17,235 | ) | ||||||||||||||
| Other (1) | (4,233 | ) | — | |||||||||||||||
| Consolidated operating earnings | $ | 68,353 | 1.49 | % | $ | 97,024 | 1.96 | % | ||||||||||
| Depreciation and amortization: | ||||||||||||||||||
| Domestic | $ | 13,630 | $ | 15,038 | ||||||||||||||
| International | 7,768 | 8,865 | ||||||||||||||||
| Proprietary Products | 3,808 | 4,440 | ||||||||||||||||
| Consolidated depreciation and amortization | $ | 25,206 | $ | 28,343 | ||||||||||||||
| Capital expenditures: | ||||||||||||||||||
| Domestic | $ | 13,804 | $ | 7,202 | ||||||||||||||
| International | 8,453 | 4,830 | ||||||||||||||||
| Proprietary Products | 2,036 | 1,427 | ||||||||||||||||
| Consolidated capital expenditures | $ | 24,293 | $ | 13,459 | ||||||||||||||
June 30, |
December 31, | |||||||||||||||||
| Total assets: | ||||||||||||||||||
| Domestic | $ | 1,945,271 | $ | 1,778,481 | ||||||||||||||
| International | 405,020 | 352,898 | ||||||||||||||||
| Proprietary Products | 387,780 | 400,885 | ||||||||||||||||
| Segment assets | 2,738,071 | 2,532,264 | ||||||||||||||||
| Cash and cash equivalents | 57,066 | 185,488 | ||||||||||||||||
| Consolidated total assets | $ | 2,795,137 | $ | 2,717,752 | ||||||||||||||
(1) Software as a Service (SaaS) implementation costs associated with significant global IT platforms in connection with the redesign of our global information system strategy.
Owens & Minor, Inc. Net Income Per Common Share (unaudited) (dollars in thousands, except per share data) | ||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||||||
| Numerator: | ||||||||||||||||||||
| Net income | $ | 20,141 | $ | 27,716 | $ | 38,926 | $ | 51,851 | ||||||||||||
| Less: income allocated to unvested restricted shares | (229 | ) | (281 | ) | (469 | ) | (560 | ) | ||||||||||||
| Net income attributable to common shareholders - basic | 19,912 | 27,435 | 38,457 | 51,291 | ||||||||||||||||
| Add: undistributed income attributable to unvested restricted shares -basic | 27 | 72 | 51 | 131 | ||||||||||||||||
| Less: undistributed income attributable to unvested restricted shares -diluted | (27 | ) | (72 | ) | (51 | ) | (131 | ) | ||||||||||||
| Net income attributable to common shareholders - diluted | $ | 19,912 | $ | 27,435 | $ | 38,457 | $ | 51,291 | ||||||||||||
| Denominator: | ||||||||||||||||||||
| Weighted average shares outstanding - basic and diluted | 59,863 | 61,502 | 60,020 | 61,588 | ||||||||||||||||
| Net income per share attributable to common shareholders: | ||||||||||||||||||||
| Basic | $ | 0.33 | $ | 0.45 | $ | 0.64 | $ | 0.83 | ||||||||||||
| Diluted | $ | 0.33 | $ | 0.45 | $ | 0.64 | $ | 0.83 | ||||||||||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20170801006742/en/
Contacts:
Truitt Allcott, 804-723-7555
Director,
Investor & Media Relations
truitt.allcott@owens-minor.com
or
Chuck
Graves, 804-723-7556
Director, Finance & Investor Relations
chuck.graves@owens-minor.com
